Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...

But so far, so good for the TROP2-directed treatment, which is off to a "smooth market launch,” according to Daiichi CEO ...

Daiichi Sankyo reaffirms US manufacturing expansion, including for Enhertu, will help with Trump's proposed tariffs. $350M ...

Hiroyuki Okuzawa, CEO of Japanese pharmaceutical giant Daiichi Sankyo, talks about the company's revenue driver in its latest report, and the lack of visibility from the impact of potential U.S.

Hiroyuki Sanada’s battle-worn Shogun armor is heading to the Osaka Kansai Expo, and it’s ready for a close-up. From April 13–20, fans can experience the SHOGUN Samurai Armor and Costume Special ...

Years ago, Hiroyuki Hosoda, a Lower House legislator from Shimane Prefecture, was answering a question in the Diet when he blurted out, “I want to promote the Izumo dialect.” I imagine he ...

Objective: Eosinophils are hallmarks in allergic type 2 inflammation and are known to release cytotoxic granule proteins that contribute to inflammation. Eosinophils develop in the bone marrow from ...